Plexus Corp. (PLXS) SEC Filings & Earnings Calls
EquiReason read 10 Plexus Corp. SEC filings in the last 12 months. Latest: 8-K on 2026-08-24 — Board approved new $100M share repurchase program, replacing current program with $9.6M remaining. Signals capital return commitment..
Source: SEC EDGAR filings · figures as of 2026-07-04 · read by EquiReason
- Market cap
- 5.8B
- P/E TTM
- 32.0
- Dividend yield
- —
- 52-week
- —
- Next earnings
- 28 Oct, in 4 days
Every filing, read
last 12 months · SECWhat happened, the numbers inside, guidance and risks. The original is one click away.
6 Aug 202610-QRisks named: Tariff and trade dispute risks, Customer forecast inaccuracies and inventory risk, Geopolitical risksopen
Risks flagged
Tariff and trade dispute risks
“These risks and uncertainties include the effects of tariffs, trade disputes, trade agreements and other trade protection measures” · word for word
Customer forecast inaccuracies and inventory risk
“the risk of customer delays, changes, cancellations or forecast inaccuracies in both ongoing and new programs” · word for word
Geopolitical risks
“the potential effect of other events outside our control, such as the conflict between Russia and Ukraine, conflict in the Middle East (including in Iran), escalating tensions between China and Taiwan or China and the United States” · word for word
29 Jul 20268-K · 2.02Revenue $1.30B (+28% y/y); Non-GAAP diluted EPS $2.32; GAAP diluted EPS $1.58; Guidance: Q4F26 revenue $1.330-1.380B; FY2026 revenue growth >20%earningsopen
Figures in the filing · each found in the filing text
| Revenue · Q3-2026 | $1.30B | +28% y/y |
| Non-GAAP diluted EPS · Q3-2026 | $2.32 | |
| GAAP diluted EPS · Q3-2026 | $1.58 | |
| Non-GAAP operating margin · Q3-2026 | 6.3% | |
| ROIC · Q3-2026 | 14.9% | |
| Manufacturing wins (annualized revenue) · Q3-2026 | $255M | |
| Funnel of qualified opportunities · Q3-2026 | $4.50B | |
| Cash cycle days · Q3-2026 | 62 |
Guidance
Q4F26 revenue $1.330-1.380B; FY2026 revenue growth >20%
Q4F26 guidance raised above prior expectations; FY2026 revenue growth >20% with >6% non-GAAP operating margin.
Risks flagged
Free cash flow usage expected for FY2026 due to working capital investments for growth.
“We now expect a usage of free cash flow for fiscal 2026 with a return to meaningful free cash flow generation in early fiscal 2027.” · word for word
7 May 202610-QNet sales $1.16B (+19% y/y); Net income $50M (+28% y/y); Operating cash flow $13M (-86% y/y)open
Figures in the filing · each found in the filing text
| Net sales · Q2-2026 | $1.16B | +19% y/y |
| Net income · Q2-2026 | $50M | +28% y/y |
| Operating cash flow · H1-2026 | $13M | -86% y/y |
| Free cash flow · H1-2026 | $-35M | |
| Aerospace/Defense revenue · Aerospace/Defense · Q2-2026 | $212M | +23% y/y |
| Healthcare/Life Sciences revenue · Healthcare/Life Sciences · Q2-2026 | $473M | +15% y/y |
| Industrial revenue · Industrial · Q2-2026 | $479M | +21% y/y |
Risks flagged
Inventory Build Risk
“Inventories $1,373,732 (Apr 2026) vs $1,229,839 (Sep 2025), an increase of $143.9M.”
Operating Cash Flow Decline
“Cash flows provided by operating activities $13,080 (H1 2026) vs $90,330 (H1 2025).”
Tariff and Trade Risk
“These risks and uncertainties include the effects of tariffs, trade disputes, trade agreements and other trade protection measures.” · word for word
5 Feb 202610-QPlexus reported Q1 FY2026 results with revenue up 9.6% YoY, gross margin down 40bps, and operating margin up 30bps.earningsopen
Figures in the filing · each found in the filing text
| Net sales · Q1-2026 | $1.07B | +10% y/y |
| Net income · Q1-2026 | $41M | +11% y/y |
| Gross margin · Q1-2026 | 9.9% | |
| Operating margin · Q1-2026 | 5.1% | |
| Diluted earnings per share · Q1-2026 | $1.51 | +13% y/y |
| Operating cash flow · Q1-2026 | $-15M | |
| Capital expenditures · Q1-2026 | $35M | +33% y/y |
Risks flagged
Inventory build risk
“Inventories increased to $1,305.3 million as of January 3, 2026 from $1,229.8 million as of September 27, 2025.”
Negative operating cash flow
“Cash flows (used in) provided by operating activities was ($15.4 million) for the three months ended January 3, 2026.” · word for word
Industrial sector weakness
“Net sales for the three months ended January 3, 2026 in the Industrial sector decreased $16.4 million, or 3.7%.” · word for word
28 Jan 20268-K · 2.02Revenue $1.07B (+10% y/y); Non-GAAP Diluted EPS $1.78; GAAP Diluted EPS $1.51; Guidance: Q2 revenue guidance $1.11-1.15B; sees potential to exceed high-end of 9-12% revenue growth goalearningsopen
Figures in the filing · each found in the filing text
| Revenue · Q1-2026 | $1.07B | +10% y/y |
| Non-GAAP Diluted EPS · Q1-2026 | $1.78 | |
| GAAP Diluted EPS · Q1-2026 | $1.51 | |
| Non-GAAP Operating Margin · Q1-2026 | 5.8% | |
| Manufacturing Wins Annualized Revenue · Q1-2026 | $283M | |
| Free Cash Flow Guidance · FY2026 | $100M |
Guidance
Q2 revenue guidance $1.11-1.15B; sees potential to exceed high-end of 9-12% revenue growth goal
Strong Q1 results at high end of guidance; Q2 guidance implies accelerating growth; raised full-year revenue outlook.
Risks flagged
Cash cycle of 69 days; working capital investments for program ramps may pressure near-term cash flow.
“Fiscal first quarter cash cycle of 69 days met our guidance and reflected working capital investments to support significant program ramps and increased customer demand.” · word for word
22 Dec 2025DEF 14AProxy statement for 2026 annual meeting, detailing executive compensation, governance, and shareholder proposals.open
Figures in the filing · each found in the filing text
| Revenue · FY2025 | $4.03B | |
| ROIC · FY2025 | 14.6% | |
| Diluted earnings per share · FY2025 | $6.26 | |
| Net income · FY2025 | $173M | |
| Economic Return · 3-year period en | 3.4% | |
| Relative TSR percentile · 3-year period en | 84.9% | |
| Shares outstanding · 2025-12-17 | 26,759,184 | |
| CEO total compensation · FY2025 | $11M | |
| Median employee compensation · FY2025 | $16963.00 | |
| CEO pay ratio · FY2025 | $639.00 |
14 Nov 202510-KNet sales $4.03B (+2% y/y); Gross margin 10.1; Operating margin 5; Guidance: Capex guided $90M-$110M for FY2026; effective tax rate 17.0%-19.0%open
Figures in the filing · each found in the filing text
| Net sales · FY2025 | $4.03B | +2% y/y |
| Gross margin · FY2025 | 10.1% | |
| Operating margin · FY2025 | 5.0% | |
| Net income · FY2025 | $173M | +55% y/y |
| Diluted earnings per share · FY2025 | $6.26 | |
| Free cash flow · FY2025 | $154M | |
| Operating cash flow · FY2025 | $249M | |
| Capital expenditures · FY2025 | $95M | |
| Return on invested capital · FY2025 | 14.6% | |
| Economic return · FY2025 | 5.7% |
Guidance
Capex guided $90M-$110M for FY2026; effective tax rate 17.0%-19.0%
Capex guidance $90M-$110M for FY2026 to support new program ramps and equipment replacement. Effective tax rate expected 17.0%-19.0%. No explicit revenue or margin guidance provided.
Risks flagged
EMEA demand decline
“EMEA net sales decreased $98.1 million, or 18.2%, as compared to fiscal 2024.”
Customer concentration
“Our 10 largest customers accounted for 49.1% and 47.8% of our net sales in fiscal 2025 and 2024, respectively.” · word for word
Tax holiday expiration
“This tax holiday will expire on December 31, 2034, and is subject to certain conditions. In fiscal 2025 and 2024, the holiday resulted in tax reductions, net of the impact of the GILTI provisions of the U.S. Tax Cuts and Jobs Act, of approximately $43.1 million ($1.59 per basic share, $1.56 per diluted share) and $37.3 million ($1.36 per basic share, $1.34 p” · word for word
Plexus Corp. — questions
- What did Plexus Corp. file recently?
- 10 SEC filings in the last 12 months. Latest: 8-K on 2026-08-24 — Board approved new $100M share repurchase program, replacing current program with $9.6M remaining. Signals capital return commitment.
Every figure on this page comes from Plexus Corp.'s own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.
How these figures are read: methodology · EquiReason.